A detailed history of Aster Capital Management (Difc) LTD transactions in Novavax Inc stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 7,782 shares of NVAX stock, worth $55,018. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,782
Previous 265 2836.6%
Holding current value
$55,018
Previous $2.13 Million 2941.95%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$6.41 - $10.82 $48,183 - $81,333
7,517 Added 2836.6%
7,782 $64.8 Million
Q4 2024

Feb 13, 2025

BUY
$7.22 - $14.68 $1,913 - $3,890
265 New
265 $2.13 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $553M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Aster Capital Management (Difc) LTD Portfolio

Follow Aster Capital Management (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aster Capital Management (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aster Capital Management (Difc) LTD with notifications on news.